Life-changing xenotransplantation breakthroughs

Organ availability has limited treatment options for decades. Game-changing xenotransplantation breakthroughs offer the promise of an entirely new model of life-saving care.

Key Topics:

• Vision: the science behind xenotransplantation enables an entirely new source of care.
• Breakthroughs: 2024 has been a landmark year for patients needing new organs.
• Challenges: meaningful hurdles remain, including immunological rejection. Solutions are in development.
• Future: clinical implications for organ replacement and potential timeline for broad availability.
• Collaboration: multidisciplinary approaches drive xenotransplantation.

Speakers:

Jason Gerberry Specialty Pharma and SMId-Cap Biotech Analyst, BofA Global Research

Tatsuo Kawai, MD, PhD Director, Legorreta Center for Clinical Transplantation Tolerance, A. Benedict Cosimi Chair in Transplant Surgery, Massachusetts General Hospital; Professor of Surgery, Harvard Medical School

Joren Madsen, MD, PhD Director, Massachusetts General Hospital Transplant Center; Paul S. Russell/Warner-Lambert Professor of Surgery, Harvard Medical School

Richard Pierson III, MD Scientific Director, Center for Transplantation Sciences, Massachusetts General Hospital; Professor of Surgery, Harvard Medical School

Leonardo Riella, MD, PhD Medical Director of Kidney Transplantation, Massachusetts General Hospital; Harold and Ellen Danser Endowed Chair in Transplantation, Harvard Medical School